About Us
Donate: If you use this site regularly and would like to help keep the site on the Internet, please consider donating a small sum to help pay for the hosting and bandwidth bill.
What We Do
The RADAAR AMR Knowledge Hub is a dedicated knowledge synthesis and translation platform designed to strengthen evidence-informed action against antimicrobial resistance (AMR). Built to support policy-decision-makers, researchers, and practitioners, the Hub consolidates AMR-related data, research, and insights into a single, accessible resource. By transforming complex evidence into practical knowledge products—including infographics, fact sheets, videos, briefing papers, and presentations—the Hub empowers decision-makers to act on reliable, data-driven information.
At its core, the Hub aims to ensure that policy and planning decisions are grounded in facts, increasing the likelihood of effective, sustainable interventions against AMR. It supports a wide community of users, including government officials, researchers, healthcare professionals, academics, students, and others working across the AMR landscape. Through synthesis, dissemination, exchange, and application of knowledge, the RADAAR AMR Knowledge Hub serves as a bridge between evidence and action.
Launched in March 2020, the RADAAR project seeks to enhance data-sharing and data use for AMR policy, planning, and advocacy across Asia and Africa. Operating through a One Health lens—encompassing human, animal, and when possible, environmental health—the project addresses a critical challenge: policy-makers need robust evidence to make effective decisions, yet many countries face limitations in sharing AMR data. RADAAR works to overcome these barriers by improving regional data-sharing, analysing how AMR data is currently used, and identifying enablers that can strengthen its application in policy development.
By ensuring that decision-makers are aware of existing evidence and recommendations, RADAAR supports the creation and implementation of strong, evidence-based AMR policies. The project is led by the International Vaccine Institute (IVI), a non-profit inter-governmental organization established in 1997 at the initiative of UNDP. Headquartered in Seoul, Republic of Korea, IVI focuses on vaccine research and development and is supported by 35 signatory countries and the World Health Organization (WHO), with Korea, Sweden, and India as key state funders.
ABOUT THE RADAAR PROJECT
Leveraging Data and Evidence to Drive Policy Action on AMR
Antimicrobial resistance (AMR) occurs when pathogens—bacteria, viruses, parasites, and fungi—develop the ability to resist the medicines designed to treat them. This resistance is driven largely by the overuse and misuse of antimicrobials such as antibiotics, antivirals, and antifungals. As resistant pathogens, often referred to as “superbugs,” spread within communities, common infections can become difficult or impossible to treat. This increases disease risk, undermines routine medical procedures like surgery, and poses a growing threat to global health.
AMR is already causing severe consequences worldwide, contributing to over 700,000 deaths annually and creating substantial economic burdens. Despite the scale of the challenge, AMR is solvable. With immediate action, informed policies, and responsible stewardship of antimicrobial medicines, the global community can curb the rise of drug-resistant infections and protect health systems for the future.
